Insider Transactions Reported by 17 Insiders of Applied Therapeutics, Inc.

Symbol
APLT on Nasdaq
Location
New York, NY

Insiders trading volume in the past year

Applied Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Shoshana Shendelman President and CEO, Director $32,251,639 05 Aug 2024
ALEXANDRIA REAL ESTATE EQUITIES, INC. 10%+ Owner $26,325,376 04 Jun 2024
Adam Hansard Chief Commercial Officer $3,950,433 14 Mar 2024
JOHN JOHNSON Executive Chairman, Director $2,915,000 19 Dec 2024
JOEL S. MARCUS Director $2,113,275 06 Jun 2024
Charles Silberstein Chief Financial Officer $400,053 07 Jan 2022
Riccardo Perfetti Chief Medical Officer $391,780 -$57,069 -13% 04 Mar 2025
Leslie D. Funtleyder Chief Financial Officer, Director $348,519 -$20,380 -5.5% 01 Jan 2026
Evan Prescott Bailey Chief Medical Officer $336,667 15 Jun 2025
Constantine Chinoporos Chief Operating Officer and Chief Business Officer $273,432 -$17,348 -6% 24 Mar 2025
Corwin Dale Hooks Chief Commercial Officer $242,000 24 Mar 2025
Steven A. Ortega Principal Accounting Officer $120,720 15 Nov 2022
Chids Mahadevan Title: Senior Vice President of Finance (Interim Principal Financial Officer) $21,353 02 Aug 2022
Stacy J. Kanter Director $7,280 -$4,816 -40% 16 Dec 2025
Catherine Thorpe Chief Accounting Officer 16 Jun 2023
JAY S. SKYLER Director 09 Jun 2025
Teena Lerner Director 09 Jun 2025

Recent Insider Transactions by Companies or Individuals for Applied Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.